Abstract
Ischemic stroke (IS) is a complex disease regarding its risk factors; among those factors, genetics has an important role. Protein C (PC) is an important antithrombotic enzyme which its genetic variations disrupt the normal cascade of blood coagulation, resulting in thrombosis and increases the chance of stroke. Therefore, we aimed to investigate three single-nucleotide polymorphisms (SNPs) located in the core promoter of PC in order to find their role in this condition in the Iranian population. Blood samples from IS patients (n = 249) and healthy volunteers (n = 203) were collected. Biochemical analysis was performed. Genotyping was conducted on the extracted DNA from blood samples via the HRM technique. Bioinformatic investigations were used to assess how these SNPs may be involved in the IS. Smoking, hypertension, low-density lipoprotein cholesterol, and fasting blood glucose were significantly different between healthy and IS groups. rs1799809 and rs1799810 SNPs were significantly more frequent among IS patients. Also, among four identified haplotypes, CGT was found associated with IS (p = 0.001). It was also found that these SNPs may interfere with the binding of transcription factors to alter the expression of PC. Our data predict that SNPs at the core promoter of PC can affect the binding affinity of transcription factors which in turn reduces the expression of PC and increases the risk of IS.
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Arboix A (2015a) Cardiovascular risk factors for acute stroke: risk profiles in the different subtypes of ischemic stroke. World J Clin Cases: WJCC 3(5):418
Bagoly Z, Szegedi I, Kálmándi R, Tóth NK, Csiba L (2019a) Markers of coagulation and fibrinolysis predicting the outcome of acute ischemic stroke thrombolysis treatment: a review of the literature. Front Neurol 10:513
Bucciarelli P, Passamonti S, Biguzzi E, Gianniello F, Franchi F, Mannucci P et al (2012a) Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism. J Thromb Haemost 10(9):1783–91
Caspers M, Pavlova A, Driesen J, Harbrecht U, Klamroth R, Kadar J et al (2012a) Deficiencies of antithrombin, protein C and protein S–practical experience in genetic analysis of a large patient cohort. Thromb Haemost 108(08):247–57
Cheng Y-C, Cole JW, Kittner SJ, Mitchell BD (2014) Genetics of ischemic stroke in young adults. Circulation: Cardiovasc Genet 7(3):383-92
Civelek GM, Atalay A, Turhan N (2016a) Medical complications experienced by first-time ischemic stroke patients during inpatient, tertiary level stroke rehabilitation. J Phys Ther Sci 28(2):382–91
Esmon CT (2003a) The protein C pathway. Chest. 124(3):26S-32S
Folsom A, Ohira T, Yamagishi K, Cushman M (2009a) Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Thromb Haemost 7(11):1774–8
Francis J, Raghunathan S, Khanna P (2007a) The role of genetics in stroke. Postgrad Med J 83(983):590–5
Horakova K, Kolorz M, Bartosova L, Pechacek V, Wroblova K (2013a) Three polymorphisms in promoter of protein C gene with endothelial protein c receptor gene and risk of venous thrombosis. Blood Coagul Fibrinolysis 24(8):814–7
Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J et al (2007a) Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med 13(11):1349–58
Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW (2001) Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 276(14):11199–203
Loubele ST, Spek CA, Leenders P, van Oerle R, Aberson HL, Hamulyák K et al (2009a) Activated protein C protects against myocardial ischemia/reperfusion injury via inhibition of apoptosis and inflammation. Arterioscler Thromb Vasc Biol 29(7):1087–92
Matarin M, Singleton A, Hardy J, Meschia J (2010a) The genetics of ischaemic stroke. J Intern Med 267(2):139–55
Ovbiagele B, Nguyen-Huynh MN (2011) Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics. 8(3):319
Reiner AP, Carty CL, Jenny NS, Nievergelt C, Cushman M, STEARNS‐KUROSAWA DJ et al (2008) PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J Thromb Haemost 6(10):1625-32
Słomka M, Sobalska-Kwapis M, Wachulec M, Bartosz G, Strapagiel D (2017a) High resolution melting (HRM) for high-throughput genotyping—limitations and caveats in practical case studies. Int J Mol Sci 18(11):2316
Vossen C, Koeleman B, Hasstedt S, Nijman I, Renkens I, Callas P et al (2013a) Genetic variants associated with protein C levels. J Thromb Haemost 11(4):715–23
Wiseman S, Marlborough F, Doubal F, Webb DJ, Wardlaw J (2014a) Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc Dis 37(1):64–75
Xing C, Arai K, Lo EH, Hommel M (2012a) Pathophysiologic cascades in ischemic stroke. Int J Stroke 7(5):378–85
Yousufuddin M, Young N (2019) Aging and ischemic stroke. Aging (Albany NY). 11(9):2542
Zhou L, Wang K, Wang J, Zhou Z, Cheng Y, Pan X et al (2019) PTPN22 Gene polymorphisms are associated with susceptibility to large artery atherosclerotic stroke and microembolic signals. Disease markers
Acknowledgements
The authors highly appreciate the contributions of the Ghaem Hospital (Mashad, Iran) and the Vasei Hospital (Sabzevar, Iran) staff during this study.
Funding
The current study was generously supported by Sabzevar University of Medical Sciences (394212163).
Author information
Authors and Affiliations
Contributions
AF and SR designed experiments; SEM performed experiments and wrote the manuscript; FB, MZ, and MG provided instruments, chemicals, and samples; AF and SR performed the analysis of data; MZ reviewed and revised the manuscript based on new bioinformatics results.
Corresponding author
Ethics declarations
Ethical Approval
Human participant’s experiments and procedures were approved by the Sabzevar University Health Research Ethics Committee (IR.MEDSAB.REC.1394.186). No animal experiments were conducted in the current paper.
Informed Consent
All participants were enrolled in the study with informed consent.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Meshkani, S.E., Fasihi, A., Badakhshan, F. et al. Protein C Promotor Haplotypes Associated with Large-Artery Atherosclerosis Stroke in Iranian Population. J Mol Neurosci 71, 2134–2141 (2021). https://doi.org/10.1007/s12031-021-01819-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-021-01819-5